Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In the coming years, experts anticipate the approval of a variety of newer GLP-1 drugs that will boast real improvements over semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) including greater weight loss, easier administration, and additional health benefits
The cell biology of systemic insulin function
To learn more about AOD-9604 or discuss whether its safety profile aligns with your health situation and goals, consider consulting with a healthcare provider experienced in peptide therapy applications
For self-pay patients, the Zepbound Self Pay program through LillyDirect offers single-dose vials at approximately $499 per month, a significant reduction from the $1,086 list price
Induction and Maintenance in Chronic Weight Management
US$ 24.70
US$ 21.06
US$ 23.60
US$ 23.90
